Bio-Blog

What is Biocompatibility and Why Does It Matter?

Aug 16, 2022 | Biocompatibility

Medical devices have been implanted in human bodies for decades, starting with the first pacemaker implanted in 1958. In fact, it is estimated that...

2022 NULA and Dr. Julius Wayne Dudley Awards Presented to Dr. Francis Karanu

Jul 11, 2022 | Awards & Recognition

Dr. Francis Karanu, Likarda’s Director of Cell Therapy and Research and Development was named the 2022 recipient of the Newton Universal Legendary...

Next Entries »

Search

Likarda Partners with VitalTE to Develop Extended-Release Injectable Hormone Therapies

Dec 11, 2024 | Press Release

Partners will leverage Likarda’s Core-Shell Spherification® platform for slow and steady release...

Is Controlled Delivery the Future of Biologics?

Oct 10, 2024 | Cell Therapy

Introduction Biologics have emerged as the cornerstone of modern medicine, revolutionizing the...

Likarda and Cold Chain Technologies Announce Exclusive Partnership to Revolutionize Cell Therapy Material Transportation and Storage

Jun 3, 2024 | Press Release

Kansas City, MO and FRANKLIN, MA, Jun 3, 2024 – Likarda, Inc., leading biotech company...

Don't miss out on new resources!

Get our monthly newsletter

Book A Call With A Scientist.

Does your cell therapy need a targeted approach? Would improving potency be a beneﬁt for your cell therapy? Are you looking for a partner who can customize a solution that ﬁts your exact needs? Discuss options with one of our team members today.

Learn More